American Century Companies Inc. Purchases 104,452 Shares of Premier, Inc. (NASDAQ:PINC)

American Century Companies Inc. boosted its holdings in Premier, Inc. (NASDAQ:PINC) by 4.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,598,731 shares of the company’s stock after buying an additional 104,452 shares during the quarter. American Century Companies Inc. owned approximately 2.70% of Premier worth $55,093,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in PINC. Brooklyn Investment Group raised its stake in shares of Premier by 61,750.0% during the fourth quarter. Brooklyn Investment Group now owns 1,237 shares of the company’s stock valued at $26,000 after acquiring an additional 1,235 shares during the last quarter. SRS Capital Advisors Inc. increased its holdings in Premier by 157.8% in the fourth quarter. SRS Capital Advisors Inc. now owns 1,284 shares of the company’s stock valued at $27,000 after purchasing an additional 786 shares during the period. Keystone Financial Group Inc. acquired a new stake in Premier in the fourth quarter valued at $37,000. Wilmington Savings Fund Society FSB bought a new position in Premier during the 3rd quarter worth $39,000. Finally, Smartleaf Asset Management LLC lifted its holdings in Premier by 297.9% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,906 shares of the company’s stock worth $40,000 after buying an additional 1,427 shares during the period. 74.41% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on PINC. Canaccord Genuity Group decreased their price target on Premier from $21.00 to $19.00 and set a “hold” rating for the company in a research note on Wednesday, February 5th. Piper Sandler reduced their price objective on shares of Premier from $21.00 to $19.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 5th. Finally, Robert W. Baird cut their price target on Premier from $20.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, February 5th. Eight equities research analysts have rated the stock with a hold rating, According to MarketBeat, Premier has a consensus rating of “Hold” and a consensus price target of $20.17.

Premier Stock Performance

Shares of Premier stock opened at $19.02 on Thursday. The stock has a market capitalization of $1.74 billion, a PE ratio of -190.18 and a beta of 0.39. Premier, Inc. has a 52 week low of $17.23 and a 52 week high of $23.56. The stock has a 50 day moving average price of $19.45 and a two-hundred day moving average price of $20.48.

Premier Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Saturday, March 15th. Shareholders of record on Saturday, March 1st were paid a dividend of $0.21 per share. The ex-dividend date of this dividend was Friday, February 28th. This represents a $0.84 dividend on an annualized basis and a yield of 4.42%. Premier’s dividend payout ratio (DPR) is presently -840.00%.

Insiders Place Their Bets

In other news, Director Helen M. Boudreau sold 2,500 shares of the business’s stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $21.42, for a total transaction of $53,550.00. Following the completion of the sale, the director now directly owns 20,668 shares of the company’s stock, valued at $442,708.56. The trade was a 10.79 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 0.96% of the company’s stock.

Premier Company Profile

Premier, Inc, together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions.